转移
上皮-间质转换
癌症研究
蜗牛
基因沉默
生物
肝细胞癌
癌变
体内
转录因子
RNA干扰
癌症
肿瘤进展
病理
医学
内科学
核糖核酸
基因
生态学
生物化学
生物技术
作者
Zheng‐Jun Zhou,Zhi Dai,Shao‐Lai Zhou,Zhiqiang Hu,Qing Chen,Yiming Zhao,Ying‐Hong Shi,Qiang Gao,Wei‐Zhong Wu,Shuang‐Jian Qiu,Jian Zhou,Jia Fan
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2014-03-18
卷期号:74 (10): 2750-2762
被引量:97
标识
DOI:10.1158/0008-5472.can-13-2509
摘要
Expression of heterogeneous nuclear ribonucleoprotein AB (HNRNPAB) has been reported to be dysregulated in tumors, but its specific contributions to tumor formation and progression are not fully understood. Here, we demonstrate that HNRNPAB is overexpressed in highly metastatic cells and tumor tissues from patients with hepatocellular carcinoma (HCC) with recurrence. We found that HNRNPAB overexpression promoted epithelial-mesenchymal transition (EMT) in a manner associated with HCC metastasis in vitro and in vivo. RNA interference-mediated silencing of the EMT factor SNAIL attenuated HNRNPAB-enhanced cell invasion in vitro and lung metastasis in vivo. Mechanistically, HNRNPAB acted to transactivate SNAIL1 transcription, which in turn inhibited transcription of the pivotal SNAIL target gene E-cadherin. Overexpression of HNRNPAB in HCC samples correlated with higher SNAIL levels, shorter overall survival, and higher tumor recurrence. HNRNPAB overexpression, alone or in combination with SNAIL, was found to be a significant independent risk factor for recurrence and survival after curative resection. In conclusion, our findings define HNRNPAB as an activator of EMT and metastasis in HCC that predicts poor clinical outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI